CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-18 | Lee Kevin Chief Executive Officer | Sale | −49 | $60.00 | $3K | 225,085 |
| 2021-10-15 | Lee Kevin Chief Executive Officer | Sale | −320 | $60.05 | $19K | 225,134 |
| 2021-10-14 | Lee Kevin Chief Executive Officer | Sale | −4,631 | $60.00 | $278K | 225,454 |
| 2021-10-11 | Lee Kevin Chief Executive Officer | Sale | −4,402 | $53.77 | $237K | 230,683 |
| 2021-10-11 | Lee Kevin Chief Executive Officer | Sale | −598 | $54.67 | $33K | 230,085 |
| 2021-10-05 | Keen Nicholas Chief Scientific Officer | Sale | −2,178 | $45.10 | $98K | 0 |
| 2021-10-01 | Keen Nicholas Chief Scientific Officer | Sale | −1,188 | $45.00 | $53K | 2,178 |
| 2021-09-23 | Smethurst Dominic Chief Medical Officer | Option exercise | +6,000 | $18.55 | $111K | 6,000 |
| 2021-09-23 | Smethurst Dominic Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −6,000 | 114,000 | ||
| 2021-09-16 | Keen Nicholas Chief Scientific Officer | Sale | −1,955 | $45.01 | $88K | 3,366 |
| 2021-09-15 | Keen Nicholas Chief Scientific Officer | Sale | −3,000 | $45.00 | $135K | 5,321 |
| 2021-09-02 | Kalowski Lee President and CFO | Option exercise | +10,000 | $9.82 | $98K | 10,000 |
| 2021-09-02 | Kalowski Lee President and CFO | Sale | −10,000 | $40.00 | $400K | 0 |
| 2021-09-02 | Kalowski Lee President and CFO | Option exercise · Employee Stock Option (right to buy) | −10,000 | 50,000 | ||
| 2021-09-02 | Keen Nicholas Chief Scientific Officer | Sale | −10,000 | $40.00 | $400K | 8,321 |
| 2021-09-02 | Lee Kevin Chief Executive Officer | Sale | −5,000 | $40.00 | $200K | 235,085 |
| 2021-09-01 | Lee Kevin Chief Executive Officer | Option exercise | +22,890 | $14.00 | $320K | 267,170 |
| 2021-09-01 | Lee Kevin Chief Executive Officer | Sale | −8,191 | $36.38 | $298K | 258,979 |
| 2021-09-01 | Lee Kevin Chief Executive Officer | Sale | −17,098 | $37.52 | $642K | 241,881 |
| 2021-09-01 | Lee Kevin Chief Executive Officer | Sale | −1,796 | $38.08 | $68K | 240,085 |
Page 19 of 26 · 520 trades